Kalaris Therapeutics, Inc. ($KLRS)
Filing Information
| Accession Number | 0001231919-26-000532 |
|---|---|
| Form Type | 4 |
| Filing Date | May 22, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
330,614
Total Value
$1,179,969.00
P&L
-3.5% ($41,531.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | May 20, 2026 | Purchase | 244,300 | $4.83 | $1,179,969.00 | 2,224,147 | Indirect | By Samsara Opportunity Fund, L.P. | View Details | |
Director | Common Stock | โ | May 20, 2026 | Other Acquisition or Disposition | 66,906 | $0.00 | $0.00 | 10,657,028 | Indirect | By Samsara BioCapital, L.P. | View Details | |
Director | Common Stock | โ | May 20, 2026 | Other Acquisition or Disposition | 14,937 | $0.00 | $0.00 | 14,937 | Indirect | By Samsara BioCapital GP, LLC | View Details | |
Director | Common Stock | โ | May 20, 2026 | Other Acquisition or Disposition | 4,471 | $0.00 | $0.00 | 19,408 | Indirect | By Samsara BioCapital Partners, L.P. | View Details |